Raymond James Reaffirms Their Sell Rating on Community Health (CYH)
In a report released yesterday, John Ransom from Raymond James maintained a Sell rating on Community Health. The company’s shares closed yesterday at $3.33.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Ransom is a 5-star analyst with an average return of 8.4% and a 57.35% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Oscar Health, Community Health, and Radnet.
In addition to Raymond James, Community Health also received a Sell from Wells Fargo’s Stephen Baxter in a report issued on February 19. However, on February 20, Oppenheimer maintained a Buy rating on Community Health (NYSE: CYH).
Based on Community Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.11 billion and a net profit of $110 million. In comparison, last year the company earned a revenue of $3.27 billion and had a GAAP net loss of $70 million
Read More on CYH:
Disclaimer & DisclosureReport an Issue
- Community Health Systems Earnings Call Shows Cautious Progress
- Community Health price target raised to $3.70 from $3.60 at UBS
- Community Health Advances Portfolio Streamlining and Debt Reduction
- Community Health reports Q4 EPS ex-items 0c, consensus (20c)
- Community Health sees FY26 EPS (60c)-0c, consensus (36c)
